Search
| Leader | 00000nz a2200037n 45 0 | ||
|---|---|---|---|
| 001 | WKP|Q57639056 (VIAF cluster) (Authority/Source Record) | ||
| 003 | WKP | ||
| 005 | 20241221010845.0 | ||
| 008 | 241221nneanz||abbn n and d | ||
| 035 | ‡a (WKP)Q57639056 | ||
| 024 | ‡a 0000-0003-2185-4999 ‡2 orcid | ||
| 035 | ‡a (OCoLC)Q57639056 | ||
| 100 | 0 | ‡a Jan H Ho ‡c researcher ORCID ID = 0000-0003-2185-4999 ‡9 en | |
| 375 | ‡a 1 ‡2 iso5218 | ||
| 400 | 0 | ‡a Jan H Ho ‡c onderzoeker ‡9 nl | |
| 670 | ‡a Author's A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin | ||
| 670 | ‡a Author's A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial | ||
| 670 | ‡a Author's Effect of Roux-en-Y Bariatric Surgery on Lipoproteins, Insulin Resistance, and Systemic and Vascular Inflammation in Obesity and Diabetes. | ||
| 670 | ‡a Author's Evidence for more intensive cholesterol lowering. | ||
| 670 | ‡a Author's Hypercholesterolaemia - practical information for non-specialists | ||
| 670 | ‡a Author's Liver Fat Measured by MR Spectroscopy: Estimate of Imprecision and Relationship with Serum Glycerol, Caeruloplasmin and Non-Esterified Fatty Acids | ||
| 670 | ‡a wikidata authority control ‡u https://viaf.org/viaf/42153833239564332487 | ||
| 909 | ‡a (orcid) 0000000321854999 ‡9 1 | ||
| 919 | ‡a hypercholesterolaemiapracticalinformationfornonspecialists ‡A Hypercholesterolaemia - practical information for non-specialists ‡9 1 | ||
| 919 | ‡a comparisonoftheeffectsoflowandhighdoseatorvastatinonlipoproteinmetabolismandinflammatorycytokinesintype2diabetesresultsfromtheprotectionagainstnephropathyindiabeteswithatorvastatin ‡A A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin ‡9 1 | ||
| 919 | ‡a comparisonoftheeffectsoflowandhighdoseatorvastatinonlipoproteinmetabolismandinflammatorycytokinesintype2diabetesresultsfromtheprotectionagainstnephropathyindiabeteswithatorvastatinpandarandomizedtrial ‡A A comparison of the effects of low- and high-dose atorvastatin on lipoprotein metabolism and inflammatory cytokines in type 2 diabetes: Results from the Protection Against Nephropathy in Diabetes with Atorvastatin (PANDA) randomized trial ‡9 1 | ||
| 919 | ‡a effectofrouxenybariatricsurgeryonlipoproteinsinsulinresistanceandsystemicandvascularinflammationinobesityanddiabetes ‡A Effect of Roux-en-Y Bariatric Surgery on Lipoproteins, Insulin Resistance, and Systemic and Vascular Inflammation in Obesity and Diabetes. ‡9 1 | ||
| 919 | ‡a evidenceformoreintensivecholesterollowering ‡A Evidence for more intensive cholesterol lowering. ‡9 1 | ||
| 919 | ‡a liverfatmeasuredbymrspectroscopyestimateofimprecisionandrelationshipwithserumglycerolcaeruloplasminandnonesterifiedfattyacids ‡A Liver Fat Measured by MR Spectroscopy: Estimate of Imprecision and Relationship with Serum Glycerol, Caeruloplasmin and Non-Esterified Fatty Acids ‡9 1 | ||
| 946 | ‡a b ‡9 1 | ||
| 996 | ‡2 RERO|A025940980 | ||
| 996 | ‡2 LC|no2014103633 | ||
| 996 | ‡2 ISNI|0000000064094967 | ||
| 996 | ‡2 DNB|1078960577 | ||
| 996 | ‡2 DNB|131423622 | ||
| 996 | ‡2 NKC|xx0231380 | ||
| 996 | ‡2 BNF|16895941 | ||
| 996 | ‡2 ISNI|0000000062190154 | ||
| 996 | ‡2 ISNI|0000000082633178 | ||
| 996 | ‡2 LC|no 95060094 | ||
| 996 | ‡2 LC|nr 91008926 | ||
| 996 | ‡2 BNF|16977684 | ||
| 996 | ‡2 LC|n 96067125 | ||
| 996 | ‡2 NLA|000036663065 | ||
| 996 | ‡2 ISNI|0000000436850154 | ||
| 996 | ‡2 ISNI|000000048013231X | ||
| 996 | ‡2 LC|no2023140010 | ||
| 996 | ‡2 ISNI|0000000041398554 | ||
| 996 | ‡2 SUDOC|231577044 | ||
| 996 | ‡2 NLA|000036714516 | ||
| 996 | ‡2 DNB|1057857319 | ||
| 996 | ‡2 LC|no 97063187 | ||
| 996 | ‡2 ISNI|0000000496797906 | ||
| 996 | ‡2 W2Z|1542227318529 | ||
| 996 | ‡2 NII|DA1453539X | ||
| 996 | ‡2 ISNI|0000000016844460 | ||
| 996 | ‡2 N6I|vtls000117877 | ||
| 996 | ‡2 BIBSYS|1707990462177 | ||
| 996 | ‡2 NLA|000036643700 | ||
| 996 | ‡2 ISNI|000000047237284X | ||
| 996 | ‡2 ISNI|0000000063858590 | ||
| 996 | ‡2 LC|n 50035272 | ||
| 996 | ‡2 LC|n 2014052235 | ||
| 996 | ‡2 SUDOC|193705605 | ||
| 996 | ‡2 RERO|A027465951 | ||
| 996 | ‡2 DNB|1317328809 | ||
| 996 | ‡2 NLA|000036664980 | ||
| 996 | ‡2 LC|no2023109739 | ||
| 996 | ‡2 LC|no2007152981 | ||
| 996 | ‡2 ISNI|0000000424446197 | ||
| 996 | ‡2 LC|nr 95012901 | ||
| 996 | ‡2 NLA|000036682176 | ||
| 996 | ‡2 SZ|118638289 | ||
| 996 | ‡2 ISNI|000000043177114X | ||
| 996 | ‡2 ISNI|0000000064157040 | ||
| 996 | ‡2 BIBSYS|4051987 | ||
| 996 | ‡2 LC|n 86014295 | ||
| 996 | ‡2 DNB|118638289 | ||
| 996 | ‡2 NUKAT|n 2017011166 | ||
| 996 | ‡2 ISNI|0000000121031904 | ||
| 996 | ‡2 NTA|38401254X | ||
| 996 | ‡2 NDL|00468408 | ||
| 996 | ‡2 N6I|vtls000035155 | ||
| 996 | ‡2 ISNI|0000000064225488 | ||
| 996 | ‡2 DNB|1344878474 | ||
| 996 | ‡2 LC|n 84053170 | ||
| 996 | ‡2 SUDOC|140484736 | ||
| 996 | ‡2 ISNI|0000000052399659 | ||
| 996 | ‡2 ISNI|0000000063678362 | ||
| 996 | ‡2 DNB|1239338767 | ||
| 996 | ‡2 ISNI|0000000063785635 | ||
| 996 | ‡2 ISNI|0000000064113005 | ||
| 996 | ‡2 NLA|000036668096 | ||
| 996 | ‡2 NDL|00907590 | ||
| 996 | ‡2 BNF|16049753 | ||
| 996 | ‡2 NTA|408045019 | ||
| 996 | ‡2 LC|no2024089006 | ||
| 996 | ‡2 DBC|87097991009641 | ||
| 996 | ‡2 SUDOC|140269266 | ||
| 996 | ‡2 J9U|987008729571205171 | ||
| 996 | ‡2 LC|n 88254777 | ||
| 996 | ‡2 LC|no 97051053 | ||
| 996 | ‡2 NSK|000781257 | ||
| 996 | ‡2 DNB|1231585781 | ||
| 996 | ‡2 LC|n 93022432 | ||
| 996 | ‡2 ISNI|0000000064066288 | ||
| 996 | ‡2 NLA|000036684272 | ||
| 996 | ‡2 LC|n 2017040754 | ||
| 996 | ‡2 LC|no 97060872 | ||
| 996 | ‡2 NII|DA02164767 | ||
| 996 | ‡2 BNF|12329826 | ||
| 996 | ‡2 LC|n 85377947 | ||
| 996 | ‡2 J9U|987007461470105171 | ||
| 996 | ‡2 J9U|987007358168505171 | ||
| 996 | ‡2 SUDOC|170708292 | ||
| 996 | ‡2 ISNI|0000000460616034 | ||
| 996 | ‡2 NSK|000255069 | ||
| 996 | ‡2 SUDOC|131797425 | ||
| 996 | ‡2 ISNI|0000000050537341 | ||
| 996 | ‡2 LC|n 79130807 | ||
| 996 | ‡2 ISNI|0000000035700294 | ||
| 996 | ‡2 ISNI|0000000076825317 | ||
| 996 | ‡2 NLA|000036614683 | ||
| 996 | ‡2 BIBSYS|1542227318529 | ||
| 996 | ‡2 CAOONL|ncf10256944 | ||
| 996 | ‡2 LC|n 2021014092 | ||
| 996 | ‡2 LC|no2005090498 | ||
| 996 | ‡2 RERO|A012673789 | ||
| 996 | ‡2 ISNI|0000000063539012 | ||
| 996 | ‡2 NLA|000036690360 | ||
| 996 | ‡2 LC|n 88646146 | ||
| 996 | ‡2 NII|DA00344076 | ||
| 996 | ‡2 LC|nr 91009809 | ||
| 996 | ‡2 LC|nr 99007995 | ||
| 996 | ‡2 NTA|43718837X | ||
| 996 | ‡2 NTA|375140794 | ||
| 996 | ‡2 ISNI|0000000081537408 | ||
| 996 | ‡2 LC|no2008131210 | ||
| 996 | ‡2 NII|DA19102899 | ||
| 996 | ‡2 LIH|LNB:_x_J_s_;=CF | ||
| 996 | ‡2 DNB|128152610X | ||
| 996 | ‡2 ISNI|000000050558767X | ||
| 996 | ‡2 ISNI|0000000110212785 | ||
| 996 | ‡2 DNB|173519725 | ||
| 996 | ‡2 NLA|000036690199 | ||
| 996 | ‡2 ISNI|0000000042350886 | ||
| 996 | ‡2 DNB|112161776X | ||
| 996 | ‡2 LC|nb2006000673 | ||
| 996 | ‡2 BIBSYS|90267640 | ||
| 996 | ‡2 NII|DA03164387 | ||
| 996 | ‡2 LC|nr 92016810 | ||
| 996 | ‡2 ISNI|0000000063716146 | ||
| 996 | ‡2 LC|no2024019761 | ||
| 996 | ‡2 BNF|17731314 | ||
| 996 | ‡2 ISNI|000000008193629X | ||
| 996 | ‡2 CAOONL|ncf13697965 | ||
| 996 | ‡2 B2Q|0000119799 | ||
| 996 | ‡2 NUKAT|n 2018286362 | ||
| 996 | ‡2 NYNYRILM|325843 | ||
| 996 | ‡2 DNB|1159180547 | ||
| 997 | ‡a 0 0 lived 0 0 ‡9 1 | ||
| 998 | ‡a Ho, Jan Hoong ‡2 PLWABN|9810689797405606 ‡3 exact title: (1.00, 'hypercholesterolaemiapracticalinformationfornonspecialists', 'hypercholesterolaemiapracticalinformationfornonspecialists') ‡3 viafid |
